Sol-Gel Technologies (SLGL) Receivables (2019 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Receivables came in at $1.1 million in Q1 2026, down 72.52% year-on-year from $3.9 million in Q1 2025, and down 45.78% on a QoQ basis from $2.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Receivables (2019 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 8 years of Receivables data on file, last reported at $1.1 million in Q1 2026.
- On a quarterly basis, Receivables fell 72.52% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 72.52% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 45.26% from the prior year.
- Receivables for Q1 2026 stood at $1.1 million, down from $2.0 million in the prior quarter.
- Over the last five years, Receivables for SLGL reached as high as $10.8 million in Q3 2022 and fell as low as $62000.0 in Q4 2022.
- Historically, Receivables has averaged $5.2 million across 5 years, with a median of $4.8 million in 2023.
- On a YoY basis, Receivables climbed as much as 1268.27% in 2022 and fell as far as 99.53% in 2022.
- Year by year, Receivables stood at $62000.0 in 2022, then jumped by 508.06% to $377000.0 in 2023, then soared by 853.58% to $3.6 million in 2024, then slumped by 45.26% to $2.0 million in 2025, then plunged by 45.78% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Receivables figures were $1.1 million in Q1 2026, $2.0 million in Q4 2025, and $9.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 7.02 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 869,000.00 |
| Dec 31, 2023 | 377,000.00 |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | 62,000.00 |
| Sep 30, 2022 | 10.78 Mn |
| Jun 30, 2022 | 10.18 Mn |
| Mar 31, 2022 | 9.66 Mn |
| Dec 31, 2021 | 13.07 Mn |
| Sep 30, 2021 | 1.39 Mn |
| Jun 30, 2021 | 956,000.00 |
| Mar 31, 2021 | 706,000.00 |